Direct detection of antibody concentration and affinity in human serum using microscale thermophoresis.

The direct quantification of both the binding affinity and absolute concentration of disease-related biomarkers in biological fluids is particularly beneficial for differential diagnosis and therapy monitoring. Here, we extend microscale thermophoresis to target immunological questions. Optically generated thermal gradients were used to deplete fluorescently marked antigens in 2- and 10-fold-diluted human serum. We devised and validated an autocompetitive strategy to independently fit the concentration and dissociation constant of autoimmune antibodies against the cardiac β1-adrenergic receptor related to dilated cardiomyopathy. As an artificial antigen, the peptide COR1 was designed to mimic the second extracellular receptor loop. Thermophoresis resolved antibody concentrations from 2 to 200 nM and measured the dissociation constant as 75 nM. The approach quantifies antibody binding in its native serum environment within microliter volumes and without any surface attachments. The simplicity of the mix and probe protocol minimizes systematic errors, making thermophoresis a promising detection method for personalized medicine.

[1]  Dieter Braun,et al.  Molecular interaction studies using microscale thermophoresis. , 2011, Assay and drug development technologies.

[2]  Dieter Braun,et al.  Protein-binding assays in biological liquids using microscale thermophoresis. , 2010, Nature communications.

[3]  D. Braun,et al.  Optical thermophoresis for quantifying the buffer dependence of aptamer binding. , 2010, Angewandte Chemie.

[4]  M. Lohse,et al.  Pathological autoantibodies in cardiomyopathy , 2008, Autoimmunity.

[5]  Hui Ning,et al.  Thermal diffusion forced Rayleigh scattering setup optimized for aqueous mixtures. , 2007, The journal of physical chemistry. B.

[6]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[7]  A. Khoynezhad Promising aspects and caveats of studies on anti‐apoptotic therapies in patients with heart failure , 2007, European journal of heart failure.

[8]  Dieter Braun,et al.  Why molecules move along a temperature gradient , 2006, Proceedings of the National Academy of Sciences.

[9]  G. Wallukat,et al.  Interaction between autoantibodies against the beta1-adrenoceptor and isoprenaline in enhancing L-type Ca2+ current in rat ventricular myocytes. , 2006, Journal of molecular and cellular cardiology.

[10]  Dieter Braun,et al.  Thermophoretic depletion follows Boltzmann distribution. , 2006, Physical review letters.

[11]  Deborah K Scott,et al.  Integrating molecular detection and response to create self-signalling antibodies. , 2004, Biochemical and biophysical research communications.

[12]  R. Piazza,et al.  Thermophoresis as a probe of particle?solvent interactions: The case of protein solutionsPresented at the 17th Conference of the European Colloid & Interface Science Society, Firenze, Italy, September 21?26, 2003. , 2004 .

[13]  Leslie Michels Thompson,et al.  A Rapid Cellular FRET Assay of Polyglutamine Aggregation Identifies a Novel Inhibitor , 2003, Neuron.

[14]  M. Fu,et al.  Is cardiomyopathy an autoimmune disease? , 2002, The Keio journal of medicine.

[15]  M. Budarf,et al.  Homogeneous assays for single-nucleotide polymorphism typing using AlphaScreen. , 2001, Genome research.

[16]  S. Ogawa,et al.  Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. , 2001, Journal of the American College of Cardiology.

[17]  J. Sun,et al.  Antibody Repertoire Development in Fetal and Neonatal Piglets. II. Characterization of Heavy Chain Complementarity-Determining Region 3 Diversity in the Developing Fetus1 2 , 2000, The Journal of Immunology.

[18]  A. Woods,et al.  Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence. , 1999, Analytical biochemistry.

[19]  M. Lohse,et al.  Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. , 1999, Circulation.

[20]  G. Wallukat,et al.  The β1-adrenoceptor as antigen: functional aspects , 1995 .

[21]  F. Waagstein,et al.  Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. , 1993, The Journal of clinical investigation.

[22]  I. Goldenberg,et al.  Assessment of immune modulation of beta-adrenergic pathways in human dilated cardiomyopathy: influence of methodologic factors. , 1992, American heart journal.

[23]  G. Wallukat,et al.  Autoantibodies against the β-adrenergic receptor in human myocarditis and dilated cardiomyopathy: β-adrenergic agonism without desensitization , 1991 .

[24]  C. Strader,et al.  Structural features required for ligand binding to the beta‐adrenergic receptor. , 1987, The EMBO journal.

[25]  G. Francis,et al.  Neurohumoral mechanisms involved in congestive heart failure. , 1985, The American journal of cardiology.

[26]  G. Wallukat,et al.  Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. , 1995, Journal of molecular and cellular cardiology.

[27]  N. Takekoshi,et al.  Dilated cardiomyopathy defines serum autoantibodies against G-protein-coupled cardiovascular receptors. , 1995, Autoimmunity.

[28]  W. Köhler Thermodiffusion in polymer solutions as observed by forced Rayleigh scattering , 1993 .

[29]  Adrenergic receptors. , 1966, Lancet.